CCA
Cravens & Co Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,135
| Closed | -$531K | – | 76 |
|
|
2024
Q1 | $531K | Buy |
19,135
+1,681
| +10% | +$46.6K | 0.44% | 43 |
|
|
2023
Q4 | $503K | Sell |
17,454
-5,758
| -25% | -$166K | 0.43% | 44 |
|
|
2023
Q3 | $770K | Buy |
23,212
+1,620
| +8% | +$53.7K | 0.72% | 32 |
|
|
2023
Q2 | $792K | Sell |
21,592
-49
| -0.2% | -$1.8K | 0.73% | 32 |
|
|
2023
Q1 | $883K | Sell |
21,641
-87
| -0.4% | -$3.55K | 0.82% | 24 |
|
|
2022
Q4 | $1.11M | Buy |
+21,728
| New | +$1.11M | 1.03% | 14 |
|